Circulating microparticles and plasma levels of soluble E- and P-selectins in patients with systemic sclerosis
- PMID: 24016306
- DOI: 10.3109/03009742.2013.796403
Circulating microparticles and plasma levels of soluble E- and P-selectins in patients with systemic sclerosis
Abstract
Objectives: Microparticles (MPs) may be involved in the pathogenesis of systemic sclerosis (SSc), which includes vasculopathy, endothelial cell activation, and coagulation activation. Circulating MPs from SSc patients were characterized and their relationship with soluble markers of vascular activation investigated.
Method: This study included 121 SSc patients [79 with limited (lcSSc) and 42 with diffuse cutaneous SSc (dcSSc)] and 49 sex- and age-matched healthy controls (HCs). The MPs were characterized by flow cytometry for annexin V (AnxV)-binding capacity and their expression of surface markers of platelets (PMPs), leucocytes (LMPs), or endothelial cells (EMPs). Plasma levels of soluble (s) E- and P-selectins were determined by enzyme-linked immunosorbent assay (ELISA).
Results: The total concentrations of MPs and of PMPs, LMPs, and EMPs were 22-42% lower in SSc patients than in HCs (p < 0.001). However, within the cell-derived MP pool, a 47% higher fraction of AnxV non-binding MPs (F-AnxV(-) MPs) was found in the SSc patients compared to the HCs (p < 0.05). The plasma levels of sE- and sP-selectins were increased by 47-64% in the SSc patients compared to HCs (p < 0.001). Multiple regression analysis showed that the raised plasma levels of sE- and sP-selectin were associated with F-AnxV(-) EMPs in dcSSc patients (p = 0.008 and p = 0.001, respectively) but not in lcSSc patients (p = 0.33 and p = 0.82, respectively).
Conclusions: While the total number of MPs was decreased, the number of F-AnxV(-) MPs increased in SSc patients. The F-AnxV(-) EMPs were associated with plasma levels of markers of vascular activation in patients with dcSSc.
Similar articles
-
Cross-sectional study of soluble selectins, fractions of circulating microparticles and their relationship to lung and skin involvement in systemic sclerosis.BMC Musculoskelet Disord. 2015 Aug 12;16:191. doi: 10.1186/s12891-015-0653-8. BMC Musculoskelet Disord. 2015. PMID: 26265409 Free PMC article.
-
Distinct features of circulating microparticles and their relationship to clinical manifestations in systemic lupus erythematosus.Arthritis Rheum. 2011 Oct;63(10):3067-77. doi: 10.1002/art.30499. Arthritis Rheum. 2011. PMID: 21702008
-
The relationship between plasma microparticles and disease manifestations in patients with systemic sclerosis.Arthritis Rheum. 2008 Sep;58(9):2845-53. doi: 10.1002/art.23735. Arthritis Rheum. 2008. PMID: 18759303
-
Circulating microparticles in systemic Lupus Erythematosus.Dan Med J. 2012 Nov;59(11):B4548. Dan Med J. 2012. PMID: 23171755 Review.
-
Platelet microparticles and vascular cells interactions: a checkpoint between the haemostatic and thrombotic responses.Platelets. 2008 Feb;19(1):9-23. doi: 10.1080/09537100701817232. Platelets. 2008. PMID: 18231934 Review.
Cited by
-
The correlation between serum E-selectin levels and soluble interleukin-2 receptors with relation to disease activity in localized scleroderma.Postepy Dermatol Alergol. 2018 Dec;35(6):614-619. doi: 10.5114/ada.2018.77613. Epub 2018 Nov 13. Postepy Dermatol Alergol. 2018. PMID: 30618531 Free PMC article.
-
Association of soluble urokinase plasminogen activator receptor levels with fibrotic and vascular manifestations in systemic sclerosis.PLoS One. 2021 Feb 22;16(2):e0247256. doi: 10.1371/journal.pone.0247256. eCollection 2021. PLoS One. 2021. PMID: 33617568 Free PMC article.
-
Platelets in Skin Autoimmune Diseases.Front Immunol. 2019 Jul 4;10:1453. doi: 10.3389/fimmu.2019.01453. eCollection 2019. Front Immunol. 2019. PMID: 31333641 Free PMC article. Review.
-
Microparticles in Autoimmunity: Cause or Consequence of Disease?Front Immunol. 2022 Apr 20;13:822995. doi: 10.3389/fimmu.2022.822995. eCollection 2022. Front Immunol. 2022. PMID: 35514984 Free PMC article. Review.
-
Microparticles: potential new contributors to the pathogenesis of systemic sclerosis?Adv Rheumatol. 2023 Apr 25;63(1):19. doi: 10.1186/s42358-023-00299-y. Adv Rheumatol. 2023. PMID: 37098600
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical